BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Prognosis
28 results:

  • 1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
    Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
    [No Abstract]    [Full Text] [Related]  

  • 2. ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.
    Luo Y; Li Q; Fang J; Pan C; Zhang L; Xu X; Qian S; Zhao X; Hou L
    Sci Rep; 2024 Jan; 14(1):197. PubMed ID: 38167641
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
    Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
    Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.
    Li Y; Tong Z; Wu X; Ouyang Q; Cai L; Li W; Yu Z; Han Z; Wang X; Li M; Wang H; Li L; Yang J; Niu Z; Wang Q; Xu B
    Int J Cancer; 2023 Nov; 153(10):1809-1818. PubMed ID: 37543965
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]    [Full Text] [Related]  

  • 6. The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence.
    Zhou D; Li M; Xu F; Zheng Q; Lu Q; Hong R; Wang S
    Ann Med; 2023 Dec; 55(1):2232299. PubMed ID: 37431586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
    Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
    Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
    Sun TH; Lu ZN; Song HT; Sun G
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
    [No Abstract]    [Full Text] [Related]  

  • 9. Multicenter study of the clinicopathological features and recurrence risk prediction model of early-stage breast cancer with low-positive human epidermal growth factor receptor 2 expression in China (Chinese Society of breast Surgery 021).
    Xin L; Wu Q; Zhan C; Qin H; Xiang H; Xu L; Ye J; Duan X; Liu Y;
    Chin Med J (Engl); 2022 Mar; 135(6):697-706. PubMed ID: 35274907
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer.
    Wen L; Zhong G; Zhang Y; Zhong M
    Bosn J Basic Med Sci; 2022 Jun; 22(3):471-480. PubMed ID: 34716699
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Spectrochemical analysis of liquid biopsy harnessed to multivariate analysis towards breast cancer screening.
    Freitas DLD; Câmara IM; Silva PP; Wanderley NRS; Alves MBC; Morais CLM; Martin FL; Lajus TBP; Lima KMG
    Sci Rep; 2020 Jul; 10(1):12818. PubMed ID: 32733086
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating tumour cells as prognosis predictive markers of neoadjuvant chemotherapy-treated breast cancer patients.
    Cui Z; Su F; Li Y; Yang D
    J Chemother; 2020 Oct; 32(6):304-309. PubMed ID: 32500819
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy.
    Park JH; Jonas SF; Bataillon G; Criscitiello C; Salgado R; Loi S; Viale G; Lee HJ; Dieci MV; Kim SB; Vincent-Salomon A; Curigliano G; André F; Michiels S
    Ann Oncol; 2019 Dec; 30(12):1941-1949. PubMed ID: 31566659
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
    Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
    Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.
    Huang H; Li J; Hu WJ; Chen MH; Chen SS; Chen C; Luo HQ; Zhou KY; Liu XG; Li XY
    J BUON; 2018; 23(4):1185-1194. PubMed ID: 30358230
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.
    Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
    World J Surg Oncol; 2018 Mar; 16(1):45. PubMed ID: 29506526
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.